These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 2458717)

  • 41. Receptor (norepinephrine), P-site (2',5'-dideoxyadenosine), and calcium-mediated inhibition of prostaglandin and forskolin-activated cyclic AMP-generating systems in human platelets.
    Siegl AM; Daly JW
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(3):229-45. PubMed ID: 2991349
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil.
    Han P; Boatwright C; Ardlie NG
    Thromb Haemost; 1983 Aug; 50(2):513-7. PubMed ID: 6314581
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclic AMP does not inhibit collagen-induced platelet signal transduction.
    Smith JB; Dangelmaier C; Selak MA; Ashby B; Daniel J
    Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):889-92. PubMed ID: 1375452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Occupancy of P2 purinoceptors with unique properties modulates the function of human platelets.
    Soslau G; Brodsky I; Parker J
    Biochim Biophys Acta; 1993 Jun; 1177(2):199-207. PubMed ID: 7684612
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelet desensitization induced by arachidonic acid is not due to cyclo-oxygenase inactivation and involves the endoperoxide receptor.
    Carmo LG; Hatmi M; Rotilio D; Vargaftig BB
    Br J Pharmacol; 1985 Aug; 85(4):849-59. PubMed ID: 2994786
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The inhibitory effects of exogenous arachidonic acid on rabbit platelet aggregation and the release reaction.
    Cattaneo M; Kinlough-Rathbone RL; Perry DW; Chahil A; Vickers JD; Lam SC; Packham MA; Mustard JF
    Blood; 1982 Nov; 60(5):1179-87. PubMed ID: 6289942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduction by arachidonic acid of prostaglandin I2-induced cyclic AMP formation. Involvement of prostaglandins E2 and F2 alpha.
    Faili A; Randon J; Vargaftig BB; Hatmi M
    Biochem Pharmacol; 1993 May; 45(9):1815-20. PubMed ID: 8388209
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibitory effect of stearidonic acid (18:4 n-3) on platelet aggregation and arachidonate oxygenation.
    Kockmann V; Spielmann D; Traitler H; Lagarde M
    Lipids; 1989 Dec; 24(12):1004-7. PubMed ID: 2559279
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on antiplatelet effects of OP-41483, a prostaglandin I2 analog, in experimental animals. II. Mechanism of its antiplatelet effect.
    Fujitani B; Wakitani K
    Jpn J Pharmacol; 1990 May; 53(1):25-33. PubMed ID: 2161965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The thromboxane antagonist, 13-azaprostanoic acid, inhibits arachidonic acid-induced Ca2+ release from isolated platelet membrane vesicles.
    Rybicki JP; Venton DL; Le Breton GC
    Biochim Biophys Acta; 1983 Mar; 751(1):66-73. PubMed ID: 6830832
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interference of eicosapentaenoic and docosahexaenoic acids with arachidonate-and U46619-induced platelet activation and desensitization.
    Hatmi M; Lussiana JP; Junien JL; Burke J; Vargaftig BB
    Biochem Pharmacol; 1988 Feb; 37(3):481-9. PubMed ID: 2827688
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R; Nenci GG; Gresele P
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new congenital defect of platelet secretion: impaired responsiveness of the platelets to cytoplasmic free calcium.
    Hardisty RM; Machin SJ; Nokes TJ; Rink TJ; Smith SW
    Br J Haematol; 1983 Apr; 53(4):543-57. PubMed ID: 6830700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of phosphatidic acid production and lysophospholipid formation in collagen-stimulated human platelets by staurosporine, a protein kinase inhibitor.
    Thomas LM; Holub BJ
    Cell Signal; 1991; 3(2):159-67. PubMed ID: 1908694
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Arachidonic acid-induced human platelet aggregation independent of cyclooxygenase and lipoxygenase.
    Maclouf J; Levy-Toledano S; Savariau E; Hardisty R; Caen JP
    Prostaglandins; 1984 Sep; 28(3):383-98. PubMed ID: 6440214
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The inhibition of arachidonic acid metabolism in human platelets by RHC 80267, a diacylglycerol lipase inhibitor.
    Oglesby TD; Gorman RR
    Biochim Biophys Acta; 1984 Apr; 793(2):269-77. PubMed ID: 6424715
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N-ethylmaleimide inhibits Ca2+ influx induced by collagen or arachidonate on rabbit platelets.
    Sato T; Hashizume T; Fujii T
    Biochim Biophys Acta; 1987 May; 928(3):266-71. PubMed ID: 3105597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential effects of ganodermic acid S on the thromboxane A2-signaling pathways in human platelets.
    Su CY; Shiao MS; Wang CT
    Biochem Pharmacol; 1999 Aug; 58(4):587-95. PubMed ID: 10413295
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase.
    Brüne B; Ullrich V
    Mol Pharmacol; 1987 Oct; 32(4):497-504. PubMed ID: 2890093
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacological modulation of activation-secretion of rat serosal mast cells by chymase, an endogenous secretory granule protease.
    Schick B; Austen KF
    Immunology; 1985 Nov; 56(3):513-22. PubMed ID: 3935569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.